Merck (MRK), What Is Behind The Fresh Attention On The Drugmaker?
Merck (MRK), What Is Behind The Fresh Attention On The Drugmaker? Simply Wall Street
Covered in this story
Analyst targets on Merck & Co.
- Morgan Stanley: $143 → $177 by Oct 2027 · Overweight via MarketBeat
- JPMorgan: $140 → $165 by Oct 2027 · Overweight via MarketBeat
- Scotiabank: $149 → $180 by Sep 2027 · sector outperform via marketbeat.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Merck & Co. →Dalsna Finance is currently tracking 29 stories mentioning Merck & Co., the earliest published 10 Jul 2026.
Summary aggregated from Simply Wall Street's public RSS feed. The full reporting belongs to Simply Wall Street — please read it on their site.